ONCT   $0.5650000000000001  -18.59% Market Closed

Oncternal Therapeutics Inc
Total Cash 21.43M
totalCashPerShare 7.24
EBITDA
Total Debt 235.00K
quickRatio 2.73
currentRatio 2.887
Total Revenue 1.85M
debtToEquity 1.492
Revenue/Share 0.625
ROA -0.6309
ROE -1.18064
grossProfits
freeCashflow -10.94M
operatingCashflow -25.19M
earningsGrowth
revenueGrowth 6.557
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -11.064919
profitMargins 0.0
enterpriseValue -16.10M
forwardPE -0.16780488
floatShares 2.71M
sharesOutstanding 2.96M
sharesShort 16.93K
sharesShortPriorMonth 24.20K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.15%
Short Ratio help_outline 0.26%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 5.322
Price To Book help_outline 0.32
earningsQuarterlyGrowth
netIncomeToCommon -35.97M
trailingEps -12.93%
forwardEps -10.25%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -3.19 3Q 2024
institutionsCount 28
lastUpdated Nov. 7, 2024, 9:27 a.m.